He was born April 18, 1924, in McMechen, W.Va., a son to the late George H. and Wilma J. Fullerton.
Most-recognized brands: Anti-infectives, December 2013
The most-recognized anti-infective brand in North America is Cipro. The brand was most-recognized by 7 percent of physicians in a survey conducted by Brand Institute Inc. during the second quarter of 2013.
FDA approves new label indications for Bayer's Advantage MultiA ...
According to the American Heartworm Society, there are conservatively 1 million cases of heartworm disease diagnosed in dogs every year. Heartworm disease most commonly results in abnormal functioning of the lungs and heart, but can affect many other organs as well. Advantage MultiA for Dogs was also approved by the FDA for the treatment and ... (more)
Wed Dec 18, 2013
Bayer appoints Kemal Malik to board with innovation role
Bayer AG has appointed Kemal Malik to its management board, giving him responsibility for innovation at the German drugs and chemicals maker.
Sat Dec 14, 2013
New market study, "Germany Pharmaceuticals & Healthcare Report Q1 2014", has been published
The result is that companies have to accept a non-negotiable reference price for their products or not to market their drug in Germany at all.
Thu Dec 12, 2013
Moberg Pharma Acquires OTC Brands from Bayer
Moberg Pharma AB, a Swedish pharmaceutical company, has signed a deal to acquire three over-the-coutner brands in the US from Bayer HealthCare.
Wed Dec 11, 2013
Contract Pharma Breaking News
Bayer, Texas U Sign Clinical Program Pact
Bayer HealthCare has signed a master agreement for the conduct of clinical trials with the University of Texas MD Anderson Cancer Center aimed at supporting collaborative clinical programs in oncology.
Mon Dec 09, 2013
California-based venture capital firm targets B.C. for investment
Ranata Oballa, a medicinal chemist, works on identifying a new drug to fight macular degeneration at the Vancouver based Inception 4, a company focusing on the development of drugs to treat retinal eye disease.
Sun Dec 08, 2013
Leading in Central MA: Entrepreneur, Jacqueline Dube
Jacqueline is a master aesthetician, a licensed massage therapist and the owner of Jacqueline Jase Face and Body Center .
Fri Dec 06, 2013
Does Pharma Only Develop Drugs For Those Who Can Pay?
At the Financial Times Global Pharmaceutical & Biotech Conference this week, Bayer AG CEO, Marijn Dekkers, is reported to have said that Bayer didn't develop its cancer drug, Nexavar for India but for Western patients that can afford it.
Thu Dec 05, 2013
Contract Pharma Breaking News
Bayer, DRGT in Strategic Formulation Pact
Bayer HealthCare and Druggability Technologies have entered into a multi-year collaboration under which Bayer will deploy DRGT's Super-API platform to support formulation efforts aimed at improving compound solubility and bioavailability.
Wed Dec 04, 2013
Bayer wins Elevit trademark appeal
Bayer Healthcare has successfully appealed a trademark decision in which confusion between two health supplement products was "potentially dangerous" to pregnant women.
Mon Dec 02, 2013
Bayer developing cancer drugs in Whippany
As Bayer HealthCare Pharmaceuticals consolidates its U.S. operations to its new headquarters in Whippany, the international drugmaker is rapidly expanding its presence in the oncology pharmaceuticals market with much of the work being done in Morris County.
Wed Nov 27, 2013
Bayer Makes Takeover Bid for Partner Algeta
LONDON/ OSLO, Nov. 26, 2013 - German pharmaceutical group Bayer has offered to pay $2.4 billion for Norway's Algeta, its partner for a new prostrate cancer treatment, a move that would give it outright control over Xofigo, a drug the two have developed jointly since 2009, if the deal is accepted.
Bayer to Expand Production Capacity of HDI & IPDI Coating Raw Materials
The rising demand for polyurethane automotive coatings has prompted Bayer MaterialScience to expand the production of two important coating raw materials: hexamethylene diisocyanate and isophorone diisocyanate .
Tue Nov 26, 2013
Eighth Circuit Addresses Scope of False Claims Act Liability
Last month, the Eighth Circuit Court of Appeals addressed the scope of "fraud-in-the-inducement" liability under the False Claims Act , 31 U.S.C. 3729-3733, and, in doing so, reversed the dismissal of a claim related to the marketing of a pharmaceutical product.
Sun Diagnostics: Advancing Laboratory Medicine and Improving Healthcare
Today, Sun Diagnostics announced the appointment of Kwok Yeung, PhD., as Chief Executive Officer.
Mon Nov 25, 2013
Bayer preparing a bid for Norwegian drug partner Algeta: paper
German pharmaceutical group Bayer is preparing a bid to acquire Algeta, its partner for its prostrate cancer treatment Xofigo, a German newspaper reported on Tuesday.
Bayer preparing a bid for Norwegian drug partner Algeta -paper
German pharmaceutical group Bayer is preparing a bid to acquire Algeta , its partner for its prostrate cancer treatment Xofigo, a German newspaper reported on Tuesday.
Former Heads for Bayer and Russell Indexes Join the Nativis Board of Directors
Nativis, Inc. , a Seattle-based life sciences company, announced today that Mr. David Grieger and Mr. John Payne were named to the company's Board of Directors.